Skip to content
Menu
0
Your cart is empty. Go to Shop
Menu
Cart
Your cart is empty. Go to Shop
Menu
Cart
Your cart is empty. Go to Shop
Menu
0
Your cart is empty. Go to Shop

BPC-157 5MG Research Overview

Introduction & Biochemical Profile

bpc-157 research

BPC-157 Research Overview: Pentadecapeptide Kinetics & Angiogenic Pathways

Introduction & Biochemical Profile

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide sequence derived from a protective protein isolated from human gastric juice. In biochemical and cellular research, BPC-157 is investigated for its pleiotropic effects, specifically its ability to modulate the vascular endothelial growth factor receptor 2 (VEGFR2) pathway, influence angiogenic signaling, and serve as a model for studying mucosal defense mechanisms in in vitro and preclinical laboratory models.

Unlike broader systemic peptides, the gastric-derived origin of BPC-157 provides a unique experimental model for examining gastrointestinal cytoprotection, brain-gut axis signaling, and cellular migration dynamics. Researchers utilize this synthetic pentadecapeptide sequence to evaluate intracellular phosphorylation cascades and receptor binding affinities in controlled laboratory environments.

Technical Specification Table

Technical Specification Table

AttributeParameter
Chemical NameBody Protection Compound-157 (BPC-157)
Sequence Length15 Amino Acids (Pentadecapeptide)
Molecular FormulaC62 H98 N16 O22
Molecular Weight1419.53 g/mol
Purity (HPLC)≥99.0%
ClassificationGastric-Derived Synthetic Peptide Sequence
Primary TargetsVEGFR2 pathway, nitric oxide synthases, and focal adhesion kinase (FAK) signaling cascades
Research ContextIn vitro angiogenesis assays, gastric cytoprotection, extracellular matrix remodeling, and cellular homeostasis models
Important Notice: All information provided on this page and across our catalog is strictly for laboratory research, educational, and analytical purposes only. These compounds are unapproved chemical reagents and are not intended for human consumption, diagnostic, therapeutic, clinical, veterinary, or dietary use of any kind.

Biological Mechanisms & Laboratory Focus Areas

Preclinical research into BPC-157 centers around several key cellular pathways:

  • Angiogenesis Modulation: Investigators utilize BPC-157 to examine the upregulation of Vascular Endothelial Growth Factor (VEGF) and the downstream activation of the VEGFR2 pathway in endothelial cell culture models.
  • Nitric Oxide (NO) Pathway Interaction: Laboratory studies monitor how the peptide interacts with nitric oxide synthesis pathways, providing a model for observing vascular tone regulation and mucosal blood flow dynamics in experimental settings.
  • Fibroblast Activation & Extracellular Matrix Studies: Research protocols evaluate peptide-mediated activation of fibroblasts, focusing on the focal adhesion kinase (FAK) and paxillin signaling pathways associated with cellular migration and matrix remodeling in vitro.
  • Gastrointestinal Cytoprotection: As a gastric juice-derived sequence, BPC-157 serves as an experimental reagent for mapping brain-gut axis signaling and cellular defense mechanisms across mucosal tissue models.

In Vitro Methodology & Experimental Protocols

In bioanalytical chemistry and cell biology, researchers evaluate BPC-157 across several core laboratory methodologies:

  1. Endothelial Tube Formation Assays: Measuring human umbilical vein endothelial cell (HUVEC) migration and capillary-like structure assembly following exposure to BPC-157 in vitro.
  2. Western Blotting & Phosphorylation Analysis: Quantifying the activation status of intracellular signaling proteins, including VEGFR2 and associated downstream kinases, in cell lysates.
  3. High-Performance Liquid Chromatography (HPLC): Monitoring chemical purity (≥99.0%), stability kinetics, and peptide integrity across various experimental buffer formulations.

Frequently Asked Questions (FAQ)

What is BPC-157 in biochemical research?

BPC-157 is a synthetic 15-amino acid peptide derived from a protective protein found in human gastric juice, utilized in laboratory studies as a reference molecule for angiogenesis and mucosal defense.

How is BPC-157 evaluated in laboratory models?

Researchers study BPC-157 using in vitro cell cultures and preclinical models to analyze VEGF receptor signaling, nitric oxide pathway interactions, and fibroblast activation markers.

What is the significance of the VEGFR2 pathway in BPC-157 research?

The VEGFR2 pathway is a primary target in angiogenesis research; investigating how peptides like BPC-157 influence this pathway provides valuable data on endothelial cell proliferation and vascular network formation in vitro.

Is BPC-157 approved for clinical, therapeutic, or human use?

Academic & Scientific References

No. BPC-157 is an unapproved investigational compound. It is not approved by regulatory bodies (such as the FDA or EMA) for human consumption, clinical treatment, or consumer administration, and is restricted strictly to non-clinical laboratory research.

Important Notice & Disclaimer: All products available through Peptronic Labs, including peptides, small-molecule compounds, and biochemical reagents, are strictly intended for laboratory research, educational, and analytical purposes only. These products are unapproved chemical reagents and are not intended for human consumption, clinical use, diagnostic procedures, therapeutic treatments, veterinary administration, or dietary supplementation of any kind. Purchasers and investigators must ensure proper handling, appropriate laboratory protocols, and full compliance with applicable local and international regulations.